These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 35752435)
1. Effectiveness of Maintenance and Reliever Therapy Using Inhaled Corticosteroid-Formoterol in Asthmatics. Kim C; Lee Y; Lee E; Chan You S; Jang JH; Park RW; Park HS J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2638-2645.e3. PubMed ID: 35752435 [TBL] [Abstract][Full Text] [Related]
2. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma]. Korn S; Vogelmeier C; Buhl R Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis. Beasley R; Harrison T; Peterson S; Gustafson P; Hamblin A; Bengtsson T; Fagerås M JAMA Netw Open; 2022 Mar; 5(3):e220615. PubMed ID: 35230437 [TBL] [Abstract][Full Text] [Related]
4. New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management. Singh D; Garcia G; Maneechotesuwan K; Daley-Yates P; Irusen E; Aggarwal B; Boucot I; Berend N Adv Ther; 2022 May; 39(5):1895-1914. PubMed ID: 35284999 [TBL] [Abstract][Full Text] [Related]
5. Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention. Aalbers R; Vogelmeier C; Kuna P Respir Med; 2016 Feb; 111():1-7. PubMed ID: 26614594 [TBL] [Abstract][Full Text] [Related]
6. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study. Vogelmeier C; Naya I; Ekelund J Clin Drug Investig; 2012 Jul; 32(7):439-49. PubMed ID: 22607479 [TBL] [Abstract][Full Text] [Related]
7. Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials. Hatter L; Houghton C; Bruce P; Holliday M; Eathorne A; Pavord I; Reddel HK; Hancox RJ; Braithwaite I; Oldfield K; Papi A; Weatherall M; Beasley R; BMJ Open Respir Res; 2022 Aug; 9(1):. PubMed ID: 36007980 [TBL] [Abstract][Full Text] [Related]
8. Direct healthcare costs associated with management of asthma: comparison of two treatment regimens in Indonesia, Thailand and Vietnam. Aggarwal B; Jones PW; Yunus F; Lan LTT; Boonsawat W; Ismaila A; Ascioglu S J Asthma; 2022 Jun; 59(6):1213-1220. PubMed ID: 33764239 [TBL] [Abstract][Full Text] [Related]
9. Safety and Effectiveness of As-Needed Formoterol in Asthma Patients Taking Inhaled Corticosteroid (ICS)-Formoterol or ICS-Salmeterol Maintenance Therapy. Reddel HK; Brusselle G; Lamarca R; Gustafson P; Anderson GP; Jorup C J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2104-2114.e3. PubMed ID: 37054881 [TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β Wang MT; Lai JH; Huang YL; Liou JT; Cheng SH; Lin CW; Pan HY; Hsu YJ; Tsai CL Chest; 2021 Oct; 160(4):1255-1270. PubMed ID: 34023320 [TBL] [Abstract][Full Text] [Related]
11. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma. Buhl R; Vogelmeier C Curr Med Res Opin; 2007 Aug; 23(8):1867-78. PubMed ID: 17605896 [TBL] [Abstract][Full Text] [Related]
12. What have we learnt about asthma control from trials of budesonide/formoterol as maintenance and reliever? Jenkins CR; Bateman ED; Sears MR; O'Byrne PM Respirology; 2020 Aug; 25(8):804-815. PubMed ID: 32237004 [TBL] [Abstract][Full Text] [Related]
13. The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today. Krings JG; Beasley R J Allergy Clin Immunol Pract; 2024 Apr; 12(4):870-879. PubMed ID: 38237858 [TBL] [Abstract][Full Text] [Related]
14. The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review. Beasley R; Bruce P; Houghton C; Hatter L J Allergy Clin Immunol Pract; 2023 Mar; 11(3):762-772.e1. PubMed ID: 36639054 [TBL] [Abstract][Full Text] [Related]
15. Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma. Beasley R; Harper J; Bird G; Dunphy H; Semprini A; Pavord ID; Papi A; Weatherall M BMC Pulm Med; 2019 Dec; 19(1):264. PubMed ID: 31883519 [TBL] [Abstract][Full Text] [Related]
16. A network meta-analysis of the association between patient traits and response to regular dosing with ICS/long-acting β Yorgancıoğlu A; Cruz AA; Garcia G; Lavoie KL; Roche N; P G A; Verma M; Majumdar A; Chatterjee S Respir Med; 2023 Nov; 218():107377. PubMed ID: 37524150 [TBL] [Abstract][Full Text] [Related]
17. Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines. Lin J; Zhou X; Wang C; Liu C; Cai S; Huang M Expert Rev Respir Med; 2018 Mar; 12(3):191-202. PubMed ID: 29400090 [TBL] [Abstract][Full Text] [Related]
18. Patterns of Asthma Medication Use in New Zealand After Publication of National Asthma Guidelines. Hatter L; Eathorne A; Hills T; Bruce P; Houghton C; Weatherall M; Beasley R J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2757-2764.e5. PubMed ID: 37178765 [TBL] [Abstract][Full Text] [Related]
19. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575 [TBL] [Abstract][Full Text] [Related]
20. Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone Monotherapy. Weinstein CLJ; Ryan N; Zhang X; Shekar T; Gates D; Lane SJ; Agache I; Nathan RA; J Allergy Clin Immunol Pract; 2020 May; 8(5):1634-1644.e1. PubMed ID: 31981733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]